Eric J. Niesor

2.4k citations
67 papers · 1.8k indexed · h-index 24
Topics
Cholesterol and Lipid Metabolism (25 papers)Cancer, Lipids, and Metabolism (25 papers)Lipoproteins and Cardiovascular Health (22 papers)

In The Last Decade

Eric J. Niesor

64 papers receiving 1.8k citations

Peers

Eric J. Niesor
Comparison fields: 5 of 98
  • Surgery 905
  • Molecular Biology 683
  • Endocrinology, Diabetes and Metabolism 546
  • Oncology 391
  • Cancer Research 361
Replace Willeke de Haan with:
Willeke de Haan Netherlands
Elaine Quinet United States
Masatsune Ogura Japan
B Angelin Sweden
Elda Favari Italy
Maria Pia Adorni Italy
Ginny Kellner-Weibel United States
Guoqing Cao China
Fumihiko Matsuura Japan
Bo Angelin Sweden
Eric J. Niesor relative to Willeke de Haan Netherlands Willeke de Haan's profile →
Citations per field
00.5×1.5×1.8×
Willeke de Haan · 1×
Citations per year

Countries citing papers authored by Eric J. Niesor

Since Specialization
Citations

This map shows the geographic impact of Eric J. Niesor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric J. Niesor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric J. Niesor more than expected).

Fields of papers citing papers by Eric J. Niesor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric J. Niesor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric J. Niesor. The network helps show where Eric J. Niesor may publish in the future.

Co-authorship network of co-authors of Eric J. Niesor

This figure shows the co-authorship network connecting the top 25 collaborators of Eric J. Niesor. A scholar is included among the top collaborators of Eric J. Niesor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric J. Niesor. Eric J. Niesor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 18
5 93
6 5
7 53
8 10
9 40
10 1
11 11
12 39
13
Abstract 1271: The Effects of Dalcetrapib on Macrophage Reverse Cholesterol Transport in a Rodent Model
3
14
Safety and Tolerability of Dalcetrapib††Conflicts of interest: Dr. Stein has received grants for studies of lipid-modifying agents, has received consulting fees and honoraria for professional input regarding agents to modify lipid profile, and/or has delivered lectures for the American Association for Clinical Chemistry, Washington, District of Columbia; Abbott Laboratories, Abbott Park, Illinois; AstraZeneca, Wilmington, Delaware; the United States Food and Drug Administration, Washington, District of Columbia; F. Hoffmann-La Roche Ltd., Basel, Switzerland; Isis Pharmaceuticals, Inc., Carlsbad, California; Merck & Co., Whitehouse Station, New Jersey; the National Lipid Association, Jacksonville, Florida; Novartis International AG, Basel Switzerland; Reliant Pharmaceuticals, Inc., Liberty Corner, New Jersey; Daiichi Sankyo Co., Ltd., Tokyo, Japan; Schering-Plough Corporation, Kenilworth, New Jersey; Takeda Pharmaceutical Company Ltd., Osaka, Japan; and Wyeth, Madison, New Jersey. Dr. Stroes has received consulting fees and honoraria from F. Hoffmann-La Roche Ltd. and Novartis International AG. Dr. Steiner has received consulting fees and honoraria from F. Hoffmann-La Roche Ltd.; Solvay, Brussels, Belgium; Ethypharm S.A., Saint-Cloud, France; and Merck Frosst Canada Ltd. (Kirkland, Quebec, Canada)/Schering-Plough Corporation. Dr. Buckley has received research grants from AstraZeneca; Merck Sharp & Dohme, Dublin, Ireland; and Pfizer, Inc., New York, New York. Dr. Buckley has received honoraria and consulting fees and/or delivered lectures for AstraZeneca; Bristol-Myers Squibb, New York, New York; F. Hoffmann-La Roche Ltd.; Novartis International AG; Pfizer, Inc.; and Sanofi-Aventis, Paris, France. Dr. Capponi has received consulting fees and honoraria from F. Hoffmann-La Roche Ltd. Dr. Burgess is an employee of Hoffmann-La Roche Inc., Nutley, New Jersey. Drs. Niesor and Kallend are employees of F. Hoffmann-La Roche Ltd. Dr. Kastelein has received research grants, honoraria, or consulting fees for professional input and/or has delivered lectures for Pfizer, Inc.; Merck Sharp & Dohme; F. Hoffmann-La Roche Ltd.; Novartis International AG; Isis Pharmaceuticals, Inc.; Kowa Pharmaceutical Company Ltd., Nagoya, Japan; Schering-Plough Corporation; and AstraZeneca.
104
15
Abstract 3618: No Increase in the In Vitro Production of Aldosterone or the Expression of CYP11B2 with the CETP Modulator Dalcetrapib (RO4607381/JTT-705), in Contrast with Torcetrapib
6
16 17
17
Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of Apomine (SR-45023A), a novel oral biphosphonate anticancer drug.
28
18 45
19 26
20 4

About Eric J. Niesor

Eric J. Niesor is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism and Surgery, having authored 67 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (25 papers), Cancer, Lipids, and Metabolism (25 papers) and Lipoproteins and Cardiovascular Health (22 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (546 citations), Cancer Research (361 citations) and Surgery (905 citations). Eric J. Niesor has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include C. Bentzen, Anne Perez, David Kallend, Cyrille Maugeais, Pascal Escher, Liliane Michalik, Béatrice Desvergne, Jennifer Rieusset, Walter Wahli and Renée Benghozi. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026